Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06362616

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
The Netherlands Cancer Institute · Academic / Other
Sex
Female
Age
51 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the acute toxicity and feasibility of repeat breast conserving therapy with preoperative accelerated partial breast re-irradiation (PAPBI) in female patients aged 51 years or older with ipsilateral recurrent or second primary low-risk breast cancer or DCIS.

Detailed description

Standard treatment for an ipsilateral breast recurrence is a salvage mastectomy. However, repeat breast conserving therapy, involving breast conserving surgery (BCS) and postoperative re-irradiation, is a feasible alternative for a selected group of patients. In the primary setting, accelerated partial breast irradiation (APBI) is an international accepted treatment for a subset of breast cancer patients. Preoperative APBI (PAPBI) leads to low complication rates, limited fibrosis/induration in a small volume and good to excellent cosmetic results compared with results reported after postoperative APBI. The aim of this study is to asses the acute toxicity and feasibility of repeat breast conserving therapy with PAPBI followed by BCS in patients aged 51 years or older with ipsilateral recurrent or second primary low-risk breast cancer or DCIS. Patients undergo PAPBI 5 times (5 x 5.2 Gray). One-two weeks after completion of PAPBI, patients undergo BCS.

Conditions

Interventions

TypeNameDescription
RADIATIONPreoperative accelerated partial breast irradiationPatients will be treated with 5 x 5.2 Gray (Gy) preoperative accelerated partial breast irradiation of the in situ tumor in the breast
PROCEDUREBreast conserving surgeryPatients will be treated with breast conserving surgery.
PROCEDURESentinel node procedurePatients will undergo a (repeat) sentinel node procedure.
PROCEDUREBiopsy track removalThe biopsy track will be surgically removed.

Timeline

Start date
2024-04-12
Primary completion
2026-10-11
Completion
2027-04-11
First posted
2024-04-12
Last updated
2026-01-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06362616. Inclusion in this directory is not an endorsement.